A quick test predicts acute coronary events

Area of Science:

• Cardiology
• Biomarkers
• Inflammation Research

Background:

• Coronary arterial wall inflammation is central to atherosclerosis and thrombosis.
• High-sensitivity C-reactive protein (hs-CRP) is a key blood marker for coronary plaque inflammation.
• Endothelial dysfunction, a consequence of inflammation, predicts cardiovascular events.

Purpose of the Study:

• To highlight the utility of hs-CRP as a predictor of acute coronary events.
• To compare the effectiveness and practicality of hs-CRP testing versus cardiac catheterization.
• To emphasize the role of hs-CRP in monitoring lipid-lowering therapy effectiveness.

Main Methods:

• Review of hs-CRP as a laboratory blood test for coronary plaque inflammation.
• Discussion of endothelial function assessment via cardiac catheterization.
• Comparative analysis of hs-CRP testing and cardiac catheterization for clinical utility.

Main Results:

• hs-CRP levels accurately reflect coronary plaque inflammation.
• Lipid-lowering therapy reduces hs-CRP levels, indicating decreased inflammation and slower calcification.
• Cardiac catheterization for assessing endothelial function carries risks, time, and cost constraints.

Conclusions:

• hs-CRP is a valuable, accessible biomarker for predicting acute coronary events.
• hs-CRP monitoring effectively verifies treatment efficacy, such as with lipid-lowering therapies.
• hs-CRP testing is a simpler, safer, and more cost-effective alternative to cardiac catheterization for assessing coronary inflammation.